Asset Details
Do you wish to reserve the book?
In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
Do you wish to request the book?
In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In vitro–transcribed guide RNAs trigger an innate immune response via the RIG-I pathway
2018
Overview
Clustered, regularly interspaced, short palindromic repeat (CRISPR)-CRISPR-associated 9 (Cas9) genome editing is revolutionizing fundamental research and has great potential for the treatment of many diseases. While editing of immortalized cell lines has become relatively easy, editing of therapeutically relevant primary cells and tissues can remain challenging. One recent advancement is the delivery of a Cas9 protein and an in vitro-transcribed (IVT) guide RNA (gRNA) as a precomplexed ribonucleoprotein (RNP). This approach allows editing of primary cells such as T cells and hematopoietic stem cells, but the consequences beyond genome editing of introducing foreign Cas9 RNPs into mammalian cells are not fully understood. Here, we show that the IVT gRNAs commonly used by many laboratories for RNP editing trigger a potent innate immune response that is similar to canonical immune-stimulating ligands. IVT gRNAs are recognized in the cytosol through the retinoic acid-inducible gene I (RIG-I) pathway but not the melanoma differentiation-associated gene 5 (MDA5) pathway, thereby triggering a type I interferon response. Removal of the 5'-triphosphate from gRNAs ameliorates inflammatory signaling and prevents the loss of viability associated with genome editing in hematopoietic stem cells. The potential for Cas9 RNP editing to induce a potent antiviral response indicates that care must be taken when designing therapeutic strategies to edit primary cells.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Biology
/ CRISPR
/ Cytosol
/ DEAD Box Protein 58 - metabolism
/ DNA
/ Editing
/ Genes
/ Genomes
/ Genomics
/ gRNA
/ Humans
/ Interferon Type I - metabolism
/ Ligands
/ Medicine and Health Sciences
/ Melanoma
/ Plasmids
/ Proteins
/ Research and Analysis Methods
/ RNA
/ RNA, Guide, Kinetoplastida - genetics
/ RNA, Guide, Kinetoplastida - metabolism
/ Viruses
